CTI BIOPHARMA CORP
CTI BIOPHARMA CORP (CTI) is a publicly traded company in the Unknown sector. Across all available filings, 1 corporate insiders have executed 2 transactions totaling $0, demonstrating a neutral sentiment with $0 in net insider flow. The most recent transaction on Apr 28, 2017 involved a transaction of 34,736 shares valued at $0.
CTI Recent Transactions
2 transactionsDate | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Apr 28, 2017 | D. Perry Matthew | Executive | Option Exercise | 34,736 | $N/A | $0 | |
| Jan 11, 2017 | D. Perry Matthew | Executive | Option Exercise | 8,403 | $N/A | $0 |
CTI Insider Activity Summary
Who Is Buying CTI Stock?
No significant insider buying has been recorded for CTI in the recent period.
Who Is Selling CTI Stock?
No significant insider selling has been recorded for CTI in the recent period.
Is CTI BIOPHARMA CORP Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for CTI is neutral with an Insider Alignment Score of 50/100 and a net flow of $0.
CTI Frequently Asked Questions
Understanding CTI Insider Activity
Insider trading at CTI BIOPHARMA CORP (CTI) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 1 insiders are actively trading CTI stock, having executed 2 transactions in the past 90 days. The most active insider is Matthew D. Perry (Executive), who has made 2 transactions totaling $0.
Related Tools
Track CTI BIOPHARMA CORP Insider Activity
Get notified when executives and directors at CTI file new Form 4 transactions